O Efeito da Fibromialgia na Qualidade do Sono de Mulheres com Obesidade

William Carvalho Costa da Silva; Renata de Campos Figueiredo; Pedro Vaissman Guinsburg; Luciane Pires da Costa

doi:10.36489/saudecoletiva.2025v15i93p14787-14898

Authors

William Carvalho Costa da Silva Graduando em Nutrição (UERJ) https://orcid.org/0009-0006-2505-1594
Renata de Campos Figueiredo Reumatologista (UERJ) https://orcid.org/0009-0005-2204-0198
Pedro Vaissman Guinsburg Doutor em Economia (University of Wisconsin) https://orcid.org/0000-0002-5722-1766
Luciane Pires da Costa Doutora em Fisiopatologia Clínica e Experimental (UERJ) https://orcid.org/0000-0002-3369-864X

DOI:

https://doi.org/10.36489/saudecoletiva.2025v15i93p14787-14898

Keywords:

Obesity, Quality of Life, Obstructive Sleep Apnea, Sleep

Abstract

OBJETIVO. To assess the influence of fibromyalgia on sleep quality in women with obesity. METHOD: A cross-sectional study was conducted with women diagnosed with fibromyalgia and obesity. Descriptive, correlation, and linear regression analyses were performed using anthropometric data and scores from the Pittsburgh Sleep Quality Index, the Revised Fibromyalgia Impact Questionnaire, and the Visual Analog Scale. RESULT: The findings revealed a positive association between Pittsburgh Sleep Quality Index scores and values from the Revised Fibromyalgia Impact Questionnaire, the Visual Analog Scale for pain, and Body Mass Index. The regression model indicated that both the impact of fibromyalgia and excess weight independently negatively affect sleep quality. CONCLUSION: Treatments aimed at improving sleep quality in women with fibromyalgia should include strategies targeting the reduction of obesity-related impacts.

Author Biography

William Carvalho Costa da Silva, Graduando em Nutrição (UERJ)

Undergraduate student in Nutrition at the State University of Rio de Janeiro (UERJ), Scientific Initiation Member of the Multidisciplinary Support Center for People with Obesity and Fibromyalgia (NAIF), located at the Piquet Carneiro University Polyclinic (UERJ).

References

- Marques AP, Espírito Santo AS, Bersaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol. 2017;57(4):356-63.

- Spaeth M, Rizzi M, Sarzi-Puttinni P. Fibromyalgia and sleep. Best Pract Res Clin Rheumatol. 2011;25(2):227-39.

- Yunus MB, Ahles TA, Aldag JC, Masi AT. Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum. 1991;34:15-21.

- Kop WJ, Lyden A, Berlin AA, Ambrose K, Olsen C, Gracely RH, et al. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis Rheum. 2005;52:296-303.

- Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep. 2007;30(4):494-505.

- Branco J, Atalaia A, Paiva T. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol. 1994;21(6):1113-7.

- Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, et al. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab. 1998;83(1):107-16.

- Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol. 1997;24:1384-9.

- Russel IJ. The promise of substance P inhibitors in fibromyalgia. Rheum Dis Clin North Am. 2002;28:353-65.

- Andersen ML, Nascimento DC, Machado RB, Roizenblatt S, Moldofsky H, Tufik S. Sleep disturbance induced by substance P in mice. Behav Brain Res. 2006;167(2):212-8.

- Wolf F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.

- Moldofsky H. Management of sleep disorders in fibromyalgia. Rheum Dis Clin North Am. 2002;28:353-65.

- Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141:846-50.

- Paiva ES, Heymann RE, Rezende MC, Helfenstein M Jr, Martinez JE, Provenza JR, Ranzolin A, Assis MR, et al. A Brazilian Portuguese version of the Revised Fibromyalgia Impact Questionnaire (FIQR): a validation study. Clin Rheumatol. 2013;32(8):1199-206.

- Williamson A, Hogartt B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798-804.

- Ruiz-Montero PJ, Segura-Jimenez V, Alvarez-Gallardo IC, Nijs J, Mannerkorpi K, Delgado-Fernandez M, van Wilgen CP, et al. Fibromyalgia Impact Score in women with fibromyalgia across Southern, Central, and Northern areas of Europe. Pain Physician. 2019;22(5):E511-6.

- Scott AJ, Webb TL, Martyn-St James M, Rowse G, Weich S. Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials. Sleep Med Rev. 2021;60:101556.

- Chasens ER, Korytnik S, Liu M. Sleep and Metabolic Syndrome. Nurs Clin North Am. 2021;56(2):203-17. doi:10.1016/j.cnur.2020.10.012.

- Molony RR, Cornish SM, Jacobson TR, Coleman WJ. Sleep, sleep apnea and the fibromyalgia syndrome. J Rheumatol. 1986;13(4):797-800.

- Alvarez LB, Tishler L, Reeves DL, Fuller JC, Harris SJ. Fibromyalgia syndrome: overnight falls in arterial oxygen saturation. Am J Med. 1996;101(1):54-60.

- Fusco SFB, Bandeira RM, Vieira SB. Anxiety, sleep quality, and binge eating in overweight or obese adults. Rev Esc Enferm USP. 2020;54:e03656. doi:10.1590/S1980-220X2019013903656.

- Lee JH, Cho J. Sleep and Obesity. Sleep Med Clin. 2022;17(1):111-6. doi:10.1016/j.jsmc.2021.10.009.

- Crofford LJ, Pillemer SR, Kalogeras KT. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 1994;37:1583-92.

- McCain GA, Tilbe KS. Diurnal hormonal variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol. 1989;16:154-7.

- Crofford LJ, Demitrack MA. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am. 1996;22(2):267-84.